To mediate fast excitatory neurotransmission in the brain, glutamate (Glu) activates different subtypes of receptor-channels called NMDA, c;r-amino-3-hydroxy+methylisoxazole-4-propionate (AMPA) and kainate receptors (Monaghan et al., 1989; Hollmann and Heinemann, 1994) . Glu also activates G-protein coupled receptors called metabotropic Glu receptors (mGluRs) that modulate the activity of enzymes producing second messengers such as phospholipase C (PLC), adenylyl cyclase, and phospholipase A2 (PLA2). They also activate or inhibit ion channels such as voltage-sensitive Ca'-and K' channels. Moreover, they modulate the activity of ligand-gated channels such as the GABA-A, AMPA, and NMDA receptors. Activation of mGluRs can therefore modulate and even mediate Glu-ergic neurotransmission in the brain (for a review, see Pin and Duvoisin, 1995) .
Cloning of cDNA encoding mGluRs revealed a large family of receptors having no sequence homology with any other known G-protein coupled receptors (GPCR) (Houamed et al., 1991; Masu et al., 1991; Abe et al., 1992; Tanabe et al., 1992; Nakajima et al., 1993; Okamoto et al., 1994; Saugstad et al., 1994) . To date eight genes coding for mGluRs have been described, giving rise to mGluR1 to 8 (for a review, see Pin and Duvoisin, 1995) . Based on their amino acid sequence identity, pharmacology, and transduction mechanisms, they can be subclassified into three groups. mGluRl and mGluRS which represent the first group, are coupled to PLC, and have Quis as their most potent agonist.
The 2nd group is composed of mGluR2 and mGluR3 which inhibit adenylyl cyclase and have (2S,l'S,2'S) 2-(carboxycyclopropyI)glycine (L-CCG-I) as their most potent agonist. The others, mGluR4,6, 7, and 8 correspond to the 3rd group, they also inhibit adenylyl cyclase but are selectively activated by L-amino-4-phosphonobutyrate (L-AP4). Multiplicity in this receptor family is augmented by the existence of splice variants. In the case of mGluRI, three splice variants called mGluR1 a to Ic have been described. In mGluRlb, the insertion of an additional 8.5 base pair exon, which contains an in frame stop codon, results in the deletion of 3 18 amino acids from the proposed cytoplasmic carboxy-terminal domain and 20 different residues at the carboxy-terminal tail (Tanabe et al., 1992) . In mGluRlc a distinct insertion at the same position results in a similar deletion and II other amino acids at the carboxy-terminus (Pin et al., 1992) . Functional analysis of these splice variants in either Xenopus oocytes or baby hamster kidney (BHK) cells revealed that all activate PLC (Pin et al., 1992; Pickering et al., 1993) . However, the Ca2+ signal generated by the shorter proteins mGluR I b and mGluR 1 c have a slower kinetic (Pin et al., 1992; Simoncini et al., 1993) . Moreover, in contrast to mGluRIa, mGluRl b seems to activate preferentially pertussis toxin (PTX)-insensitive G-proteins, and does not potentially activate adenylyl cyclase (Pickering et al., 1993) . Finally, the subcellular distribution of mGluRla and b expressed in BHK cells are different (Pickering et al., 1993 
Materials and Methods
Clotring c!f' mGIuR5a and mGluR5h cDNA. A set of primers was used to amplify the cDNA fragment coding for the entire C-terminal intracellular domain of mGluR.5. The sense primer MGRS-I (5'.GTG CGC AGC GCC TTC ACA ACC TCT AC-3') is located uustream of an Sphl site, corresponding to position 2494425 19 (Abe et al., 1992) . The antisense primer corresponds to the 3' end of the untranslated region of the published mGluR5 sequence: MGR5-2, 5'CTC ATG TCT AGA CCG TGT GTG TCC TTG CC-3'; italicized in MGR5-2 is an XbaI site included to facilitate subcloning of the PCR products. DNA prepared from a rat forebrain random primed cDNA library constructed in the lambda Zap vector (generous gift of Dr. Jane Sullivan) was used as template. A single band of about 1200 bp was obtained after 40 cycles of amplification (denaturation at 94°C for 30 set, annealing at 60°C for 30 set and elongation at 72°C for 90 set). After subcloning into the pBluescript vector the PCR fragments were subjected to restriction map analysis. Among the eight clones analyzed, six had a BglII-SphI fragment longer by about 100 bp than expected according to the published mGluR5 sequence. DNA sequencing using the dideoxynucleotide method and sequenase (U.S. Biochemicals) revealed the presence of an insertion of a 96 bp fragment in these clones.
To obtain full length mGluR5a and mGluR5b cDNA, a rat forebrain random primed cDNA library (500,000 clones) was screened at high stringency using as a probe the mGluR5 PCR product obtained as described above. The plasmid were rescued from the positive clones according to the manufacturer protocol and subjected to restriction map analysis. Clone B6 was found to contain most of the coding sequence of mGluR5 with the 96 bp insertion characteristic of mGluR5b. Its 5' end corresponds to position 399. The mGluR5 3' end was obtained by PCR using the oliaonucleotides MGRS-IS (5'.TCT TTA TTA GCT TGA ATT-CCT TT? C-3') and MGRS-I lAS'(5'-ATC TTT GAA AGC CTC CAT CCC-3') as primers and subcloned into pB6 after digestion with EcoRI and Ncol. The full length mGluR5a and b cDNAs were constructed using the PCR fragments corresponding to the C-terminal domain of mGluR5a and mGluR5b obtained as described above. The sequence of DNA fragments obtained by PCR were verified using the dideoxynucleotide method and Sequenase (U.S. Biochemicals).
Purtitrl (.htrrtrc.trri~trtion of mGluR.5 gene. Genomic southern blots were performed using IOkg of digested rat DNA per lane. Random primed synthesis of the radioactive probe and high stringency hybridization were carried using conventional methods.
A rat genomic library constructed in Lambda phages EMBLS (Clonetech) was screened with the insert of clone B6 as a probe using conventional methods. Ten positives were isolated and analyzed. Lambda DNA was purified and analyzed using several restriction enzymes. After blotting and hybridization with mGluR5b cDNA, a single band of 4.5 kb was labeled in most cloned DNA digested with BarnHI. After subcloning in the BamHl site of the pBluescript vector, this genomic fragment was subjected to restriction map analysis and partial sequencing.
In situ hybridizution.
In situ hybridization histochemistry was performed as described (Mengot et al., 199 1) . Briefly, Wistar rats (male, 200-300 gm) were killed by decapitation and the brains were quickly removed and frozen. Fifteen micrometer thick tissue sections were thaw mounted on gelatinized glass slides. The oligonucleotides specific for mGluR5a and mGluR5b mRNA (Bioprobe Systems, France) were complementary, respectively, to bases 2608-2647 (MGR5-19, 5'.TC ACA GAT TTT CCG TTG GAG CTT AGG GTT TCC CCA GAG GA-3') and to bases 2641-2680 located in the specific sequence of mGluR5b (MGR5-18, 5'.GG GTG AAA CAC TCT ATT TCC GAC TTG TGC TGG GCC AGT CT-3'). The oligomers were labeled at their 3' end by the terminal transferase reaction-with a"P-dATP and shown to specificallv label mGluR5a and mGluR5b cDNA on Southern blots. resnectively. The in situ hybridization was carried out overnight at 42°C as described (Mengot et al., 1991) , with 50% formamide. Sections were then washed at 55°C in I X SSC (150 mM NaCl, I5 mM Na citrate (pH 7.0) for 30 min. Tissue sections were dehydrated and placed in contact with Hyperfilm beta-max (Amersham) for 2 weeks. We have not been able to obtain nice and specitic signal with the oligonucleotide specific for mGluR5a (MGR5-19) (data not shown).
RT-PCR ofmGluR5a und mGluR5b. Total RNA were extracted from rat brain by conventional methods (Chomczynski and Sacchi, 1987) . The reverse transcription reaction was conducted using 1 kg of total RNA with 50U M-MLV reverse transcriptase (GIBCO-Bethesda Research Labs) in a 20 ~1 reaction containing 100 pmol of nonamer random primers (Bioprobe Systems), 1 mM dNTP (Pharmacia), IO mM DTT in the reaction buffer supplied by the manufacturer (GIBCO-Bethesda Research Labs). Following IO min at room temperature to allow annealing of the random primers, the reaction was conducted at 42°C for 1 hr and stopped by denaturation of the enzyme at 95°C for 10 min. The PCR reaction was performed using I pl of the RT reaction, 2.5 U of Taq DNA polymerase (Promega), 400 FM dNTP 50 pmol of each primer, in the PCR buffer supplied by the manufacturer (Promega) and supplemented with MgC12 (3 mM). Reaction was as follows: denaturation at 94°C for I min followed by 35 cycles (denaturation at 94°C for 30 set, annealing at 55°C for 30 set and elongation at 72°C for 30 set). The oliponucleotides used were olipo 5-20 for the sense primer (5'. GTT TTT CAG TCA GCC TCA GTG CC-3') and oligo 5121 for the antisense mimer (5'.CGT TTG GTT GGG GTT CTC CTT CT-3').
RNA tr~~nscripfion and exprrsxion in Xenopus oocytes. The preparation of oocytes and the in virro synthesis of RNA transcripts from the cloned cDNA have been reported (Pin et al., 1992) . The pmGR5a and pmGR5b were linearized with XhoI prior to sense-strand RNA transcription with T3 RNA polymerase; IO ng of each cRNA was injected per oocyte unless otherwise indicated. Recordings were performed in Barth's medium using the two electrode voltage-clamp technique (Axoclamp-2A) 3-5 d after injection. Data were recorded on a PC computer and analyzed using the PC' LAMP software.
Culture and trunsjtiction <$ LLC-PKl crlls. Culture and electroporation of the porcine kidney epithelial cells LLC-PKI were conducted as described (Spengler et al., 1993) . Briefly, cells were cultured in DMEM (GIBCO-Bethesda
Research Labs) supplemented with 10% fetal calf serum and antibiotics (penicillin and streptomycin 100 U/ml final). The cDNA encoding mGluR5a and mGluR5b were directionally subcloned into the eukaryotic expression vector pRK5 between the restriction sites EcoRI and XbaI of the poly-linker. These plasmids were named pRKG5a and pRKG.Sb, respectively. Electroporation was performed in a total volume of 300 pl with 10 pg of carrier DNA (plasmid DNA without insert), 200-600 ng of plasmid DNA and IO million cells in electroporation buffer (K!HPO,, 50 mM; CH,COOK, 20 mM; KOH, 20 mM). After electroporation (260 V, 960 p& Bio-Rad gene pulser electroporator), cells were resuspended in DMEM supplemented with 10% fetal calf serum and antibiotics, and split in I2 well clusters (Falcon) (10 million cells per cluster).
Determination oflP acxwnulation.
Determination of TP accumulation in transfected cells was performed as previously described (Manzoni et al., 1990) . Eight to IO hr after electroporation, cells were washed and incubated for I2 hr in DMEM-glutamax-I (GIBCO) containing I p,Ci/ ml 'H-myo-inositol (23.4 Ci/mol; New England Nucledr). Cells were then washed three times and incubated for l-2 hr at 37°C in I ml of HEPES buffer saline (NaCI 146 mM, KCI 4.2 mM, MgClz 0.5 mM, glucose 0.1 %, HEPES 20 mM/pH 7.4). Cells were then washed again twice with the same medium and preincubated for IO min in medium containing IO mM LiCI. Agonist was then added for a period of 30 min. The reaction was stopped by replacing the incubation medium with I ml perchloric acid (S%), on ice. The total IP were then extracted and purified on Dowex columns as previously described (Manzoni et al., 1990) . Total radioactivity remaining in the membrane fraction was counted after solubilization in IO% Triton X-100, 0. IN NaOH and used as standard. Results are expressed as the amount of IP produced over the radioactivity present in the membranes. Drtrrminck~n oft,AMP accurr~ulution. The cellular CAMP production was measured using the prelabeling technique as previously described (PrCzeau et al., 1994) . Eight to IO hr after being electroporated, cells were washed and incubated for I2 hr in DMEM-glutamax-I containing I pCi/ml 'H-adenine (24 Ci/mol). Cells were then washed three times and incubated for I .5 hr at 37°C in I ml of HEPES buffer saline. Cells were then washed again twice with the same medium containing 0.75 mM IBMX and then stimulated for IO min with I mM Glu. The reaction was stopped by aspiration of the media and addition of I ml ice-cold 5% trichloroacetic acid. Cells were scraped and 100 pl of 10 mM ATP and IO mM CAMP were added to the mixture. Cellular proteins were removed by centrifugation at 5000 X g and 'H-ATP and 'H-CAMP were separated by sequential chromatography on Dowex and alumina columns. CAMP formation is expressed as percentage conversion of 'H-ATP to 'H-CAMP:
Glu concentration in the incubation medium was determined as previously described using precolumn derivatization with orthophthalaldehyde and separation on a reversed phase Cl 8 HPLC column (Pin et al., 1986) .
lmmurzostair~irz~ rfrltf cor+~ctr/ micro.scopr rxprrimenrs.
Immunostaining experiments were performed essentially as previously described (Didier et al., 1992) . Briefly, cells grown on coverslips were fixed with 4% paraformaldehyde in 120 mM glucose for 20 min at room temperature. Coverslips were rinsed in 0.1 M glycine (pH 7.4) for 30 min and then permeabilized with 0.05% Triton X-100 in phosphate buffer saline (PBS) for IO min. After washing with PBS containing 10% gelatin (PBS-gelatin), cells were incubated with the anti-mGluRS antibody (I: 200) in PBS-gelatin buffer over night at 8°C. The mGluR5 antibody (m5.12, generous gift of Dr. C. Romano, Washington University School of Medicine, Saint Louis, MO) was raised against a peptide corresponding to the I3 C-terminal residues of mGluR5 and was shown not to cross-react with mGluRla (Roman0 et al., 1994) . Coverslips were washed three times, for 30 min with PBS-gelatin buffer and exposed to goat anti-rabbit IgG second antibody conjugated to rhodamine (Sigma, Lisle d' Abaud, France), I : 100 in PBS-gelatin buffer for l-2 hr at room temperature. After washing with PBS-gelatin, coverslips were mounted on glass slides, and visualked with a Bio-Rad MRC 600 confocal microscope.
A4urrriul.s.
(S)-3-hydroxyphenylglycine (3HPG) were obtained from Tocris Neuramin (UK). The four stereoisomers of ACPD, IS,3R-ACPD, I K,.?S-ACPD, I S,3S-ACPD, and IR,3R-ACPD were synthesized as previously described (Curry et al., 1988 (Minakami et al., 1993) . The mGluR5b inserted cassette contains no stop codon in frame, so that the mGluR5b protein is expected to contain 32 additional amino acids located in the cytoplasmic tail, 50 residues after the 7th TMD (Fig. I ) . Interestingly, two putative phosphorylation sites, one for PKA and one for PKC, are present in this cassette. In contrast to mGluR1 b and mGluRlc, mGluR5b protein still possesses a long C-terminal intracellular domain, like mGluR I a and mGluR5a (Fig. 1) . It is likely that the mGluR5b cDNA is generated by alternative splicing of a single premessenger RNA for several reasons. First, Southern blots performed with rat genomic DNA digested with EcoRI or BamHI and hybridized with a radioactive probe corresponding to the 7 TMD region of mGluR5 revealed a single band (3.1 and 4.5 kb, respectively), indicating that a single mGluR5 gene exists (data not shown). Second, screening of a rat genomic library with a mGluR5 probe allowed us to isolate a 20 kb genomic clone. After digestion of this clone with BamHI, a single band of 4.5 kb hybridizes with mGluR5b cDNA used as a probe. This 4.5 kb fragment contains a single exon corresponding to the 7 TMD region of mGluR5 (Fig. 2) . This exon ends exactly at the position were the mGluR5b cassette is inserted, and the following sequence in the mGluR5 gene corresponds to a splice donor consensus site. Interestingly, this exon corresponds almost exactly to its equivalent in the mGluR1 gene (Fig. 2) .
In order to verify that mGluR5b mRNA are present in the brain, mRNA isolated from different brain area were reversed transcribed and subjected to PCR amplification using oligonucleotide primers located on both side of the cassette. These primers allow the amplification of both mGluR5a and mGluR5b mGluR5 gene cDNA in a competitive manner, giving rise to two PCR products that have different size. The mGluR5b product (43 l bp) is longer by 96 bp than the PCR product obtained from mGluRSa cDNA (335bp) (Fig. 3) . In all brain regions examined, both products were obtained, whereas no amplification products could be detected when spleen RNA were used (Fig. 3) . This indicates that both mGluR5a and mG1uRSb mRNA are present in the brain. Moreover, since the amount of the PCR product corresponding to mGluR5b is always higher than that of mGluRSa, it is likely that the mRNA for mGluR5b is present at a higher density in the adult brain. The regional distribution of mGluR5b mRNA was examined by in situ hybridization using the mGluR5b specific oligonucleotide (Fig, 4) . Intense labeling was found in the CAI and CA3 fields of the hippocampus, in the dentate gyrus, the striatum, the lateral septal nucleus and in the cortex (Fig. 4) . This distribution corresponds exactly to that reported for mGluR5 mRNA, using a probe that did not discriminate between mGluR5a and mGluR5b mRNA (Abe et al., 1992) .
The transduction mechanism of mGluR5b was first examined after expression of the receptor protein in Xeno>pus oocytes. In these cells, stimulation of PLC-coupled receptors leads to the activation of an oscillatory Cl---current resulting from the release of Ca?' from internal stores (Hirono et al., 1987) . In these oocytes, mGluR I a generates rapid and transient responses, whereas mGluRl b and c induce more slowly generating oscillatory responses (Pin et al., 1992) . Like mGluRla, mGluRSa, and mGluR5b activate a current (Fig. 5 ) which reverses around -20 mV as expected for a Cl--current in these cells (data not shown). Both mGluR5a and mGluR5b-mediated responses are transient, generate rapidly and are not followed by long lasting oscillations. As shown on Figure 5 , the responses always peak during the first 15 set, whatever the amount of cRNA injected into the oocytes. The time needed to reach the peak current is 6.27 + 0.37 set (n = 1 11) and 5.39 & 0.32 set (n = 138) for mGluR5a and mGluR5b respectively (means +-SEM, values not statistically different). These values are 4.41 + 0.31 (n = 202) and 13.37 + 0.94 (n = 135) for mGluRl a and mGluRl c respectively (p < 0.001). Both mGluR5a and mGluR5b mediated responses resemble therefore those generated by mGluRla.
Coupling of mGluR5a and mGluR5b to PLC was examined after transient expression into LLC-PKl cells. Stimulation of cells expressing mGluR5a or mGluR5b with Glu results in a two-to threefold increase in the amount of IP (Fig. 6 ). This Glu effect was not observed on cells transfected with the carrier DNA alone. Surprisingly, the basal level of IP production in cells transfected with mGluR5a or mGluR5b is about twofold higher than that measured on control cells. Such an increase in basal PLC activity is also observed in cells expressing mG1uRla mGluR5b-w mGluR5a + Figure   3 . RT-PCR analysis of mGluR5a and b mRNA from different brain regions. Total RNA were prepared from different regions of the rat brain and spleen, reverse transcribed and used as template in a PCR reaction bP using primers annealing on both sides of the mGluRSb cassette. hybridization. An horizontal section of an adult rat brain was hybridized with a J7P-labeled oligonucleotide specific for mGluRSb, washed at high stringency and then autoradiographed.
In the same experiment, no labeling was observed with a missense oligonucleotide or after treatment of the slice with RNases (not shown). CA1 and CA3, CAI and CA3 fields of the hippocampus; Ch, cerebellum: Ctx, cortex; DC, dentate gyms; LS, lateral septum; S, subiculum; SW, striatum.
but not in those expressing mGluRlb or c (unpublished observations). This basal activity is unlikely due to low concentrations of Glu present in the incubation medium since even after 1 hr incubation with the cells, Glu concentration in the medium was found to be 0.3 p,M, a concentration not sufficient to activate mGluR5 expressed in LLC-PKl cells (see Fig. 10 ) or in Xenopus oocytes (data not shown). Moreover, the basal activity is not inhibited by an enzyme degrading Glu, glutamate pyruvate transaminase in the presence of 2 mM pyruvate (Fig. 6 ). Taken together, these results suggest that both mGluR5a and mGluRSb, like mGluR1 a, are slightly active even in the absence of agonist.
Activation of adenylyl cyclase has been observed with mGluRla expressed either in Chinese hamster ovary (CHO) cells (Aramori and Nakanishi, 1992) or in baby hamster kidney (BHK) cells (Pickering et al., 1993) . Similarly, Glu stimulates CAMP production in LLC-PKl cells expressing mGluRla but not in those expressing mGluRlb (Fig. 7) . In these cells, mGluR5a and mGluR5b also stimulate CAMP production (Fig.   7) . Differences in the subcellular distribution of mGluRla and mGluRlb expressed in BHK .cells have been described (Pickering et al., 1993) . Whereas the mGluRla receptor proteins are localized to patches along the plasmalemma membranes and intracellularly around the nucleus, mGluRlb is distributed diffusely throughout the cell. Similar data where obtained when mGluRla and mGluRlb are expressed in LLC-PKl cells (unpublished data). Immunofluorescence imaging of mGluR5a and mGluR5b expressing cells show intense labeling. As with mGluRla expressing cells, the staining is concentrated intracellularly around the nucleus (Fig. 8a,b ) and can be seen as "wrinkles" on the top of the cells (Fig. 8c,d) , and as patches along the plasma membrane contacting the plastic of the petri dish ( Fig. 8e-g ). No labeling of cells transfected with mGluR1 a (Fig.  8h) or carrier DNA alone (data not shown) was observed.
Since mGluR5b contains additional putative phosphorylation sites for PKC and PKA compared to mGluRSa, the effect of PKC and PKA activators on IP production stimulated by these receptors was examined. The PKC activator phorbol-dibutyrate (PdBu) dose dependently inhibits Glu-induced IP production in cells expressing mGluR5a or mGluR5b (Fig. 9u,d ). The maximal inhibition observed is close to 50%, and the IC50 around 10 nM, in agreement with the reported potency of PdBu in activating PKC. The PKC inhibitor staurosporine has no effect on its own (Fig. 9b,e) but reversed the inhibition induced by PdBu indicating that the PdBu effect results from PKC activation ( After a IO min incubation 'in Krebs' medium containing 10 mM LiCI, cells were incubated for a further 30 min in the same medium (B~rse) or after addition of IO X concentrated Glu solution (1 mM final concentration), in the absence (CT!?) or in the presence (GPT) of I U/ml glutamate-pyruvate transaminase and 2 mM sodium pyruvate. Results are expressed as the ratio of 'H-IP produced over total radioactivity in the membranes, and are means k SEM of triplicate determinations from a typical experiment. 9c,,f'). Similar effects of PdBu and staurosporine were observed on mGluRSa and mGluRSb stimulation of CAMP production (data not shown). The effect of activating PKA activity on the IP production stimulated by mGluR5a and mGluR5b was also examined.
PKA activity was stimulated in different ways. First, adenylyl cyclase activity was stimulated by using either its direct activator forskolin, or vasopressin that activates V2 receptors present on these cells (Spengler et al., 1993) . Second, the intracellular concentration of CAMP was increased using the. phosphodiesterase inhibitor isobutylmethylxanthine (IBMX). Finally, direct activation of PKA with the membrane permeable analog of CAMP, 8Br-CAMP was used. None of these drugs modified the basal and the Glu stimulated IP production in cells expressing either mGluR5a or mGluR5b (data not shown). The agonist pharmacological profile of mGluR5a and mGluR5b was compared to that of mGluRla. On mGluR5a or mGluRSb, Quis was the most potent agonist, followed by Ibo, Glu, and t-ACPD (Fig. 10) . No difference in the potency of these drugs on mGluR5a and mGluR5b can be noticed (Table 1) . Interestingly, the pharmacological profile of these mGluR5 variants is slightly different from that of mGluRla expressed in the same cells. Quis, lbo, and t-ACPD are 10, 5, and 2 times more potent on mGluR5 than on mGluRla, whereas Glu has about the same potency on these receptors (Table I) . t-ACPD is composed of two stereoisomers, I S,3R-ACPD and lR,3S-ACPD. Both isomers activate mGluRla, mGluR5a and mGluRSb, lS,3R-ACPD being IO times more potent than lR,3S-ACPD (Table I ) . Both isomers are more potent on mGluR5 than on mGluR 1 a. The other isomers I S,3S-ACPD and lR,3R-ACPD are less active (Table 1) or mGluR5b expressing cells (Fig. 1 la) . Although 4C3HPG (1 mM) slightly inhibits mGluR5 stimulation of PLC, it also stimulates IP production in both mGluR5a and mGluR5b expressing cells (EC,, 2 300 FM) suggesting that it acts as a partial agonist on these mGluR subtypes (Fig. 1 la) . Under identical conditions, all these compounds antagonize Glu responses on mGluRla expressing cells (Fig. 1 lb) . 3HPG which is a partial agonist at mG1uRla (EC,,, = 100 FM), is also a partial agonist at both mGluR5a and mGluR5b (EC,,, = 35 FM) ( Fig. 1 lu,b ).
Discussion
Recently, several splice variants for GPCR have been described (for a review, see Journot et al., 1994) . Some of these variants are truncated receptors lacking transmembrane domains, and have generally no characterized function. In other cases, cassettes are inserted in the first or third intracellular loops, resulting in most cases in no major difference in the transduction mechanism, except in the case of the PACAP-receptor (Spengler et al., 1993) . A third type of GPCR splice variants corresponds to those having different C-terminal domains.
In the case of the prostaglandin EP3 receptor, changing the C-terminal domain generates receptors that have different transduction mechanisms (Namba et al., 1993; Sugimoto et al., 1993) and desensitization properties (Negishi et al., 1993) . In the mGluR family, the shorter variants mGluR1 b and mGluRlc have some functional characteristics different from those of the longer protein mGluRla ( Table 2 ), suggesting that this long C-terminal domain may play some roles in the functional coupling to G-proteins. Moreover, the N-terminal part of the C-terminal domain of mGluR1 has been shown to play a critical role for its coupling to PLC .
In the present study, we show that the mGluR5b cDNA, whose sequence has recently been published (Minakami et al., 1993) Figure 9 . Effect of PKC activation on IP production by mGluR5a and mGluR5b. 'H-inositol-labeled LLC-PKI cells transiently expressing mGluR5a (u-c) or mGluR5b (d-f'), were preincubated for 10 min in Krebs' medium containing IO mM LiCl and the indicated concentration of PdBu (n, d), or staurosporine (h, e). Cells were then incubated for a further 30 min in the same medium (qen c-in-1e.r) or stimulated by adding 10X concentrated Glu solution (I mM final; solid circles). In c and,f, cells were preincubated with Krebs' medium alone (CTR) or containing 300 nM PdBu (P&u), 300 nM staurosporine alone (Sfauro) or with 300 nM PdBu (PdBu+St). Cells were then incubated for a further 30 min in the same medium (light bars) or stimulated by adding 10X concentrated Glu solution (1 mM final; durk bars). Results are expressed as the ratio of 'H-IP produced over total radioactivity in the membranes, and are means i-SEM of triplicate determinations from typical experiments.
amino acid insertion after the 7th TMD. Therefore, in contrast to the truncated mGluR1 splice variants, mGluRlb and mGluRlc, the expected mGluR5b protein still possesses a very long C-terminal intracellular domain. Accordingly, the mGluR5b protein can be detected using an antibody directed against a peptide corresponding to the C-terminal end of mGluR5a. RT-PCR analysis revealed that mGluR5b mRNA may be expressed at a higher level than mGluR5a mRNA in the adult brain. Accordingly, the distribution of the mGluR5b mRNA in the brain is identical to that already reported for mGluR5, using a nonselective probe (Abe et al., 1992) . It is still possible that alternative splicing of mGluR5 mRNA, as already described for mGluR1 (Pin et al., 1992) , may depend on the cell type analyzed so that mGluR5a and b mRNA have slightly distinct distribution in the brain. To analyze this possibility, and due to the predominance of the mGluR5b mRNA, it is necessary to specifically localize mGluR5a mRNA. Unfortunately, the oligonucleotide which may specifically label mGluR5a did not allow us to obtain t specific labeling. It is also possible that the distribution and the level of expression of each variant vary during development.
Our functional analysis of mGluR5a and mGluR5b revealed no difference in their coupling to PLC in either Xenopus oocytes or mammalian cells. Both receptors, like mGluRla, induce a rapid and transient response in X~nc)pu.s oocytes. This indicates that they induce a rapid and transient Ca'+ signal since the activation of the Cll-current has been shown to reflect nicely the variation in the intracellular Ca'+ concentrations (Lechleiter et al., 1991) . In LLC-PKI cells, both receptors stimulate the production of IP when activated with Glu. Although mGluR5b contains two additional putative phosphorylation sites, one for PKC and one for PKA, both mGluR5a and mGluR5b coupling to PLC are diminished after PKC activation, and are not sensitive to PKA. It is possible that the inhibition of the IP production observed after PKC activation results from a downregulation of a component downstream of the receptor, such as PLC itself (Cockcroft and Thomas, 1992) . Such an effect may mask a pu- tative direct effect of PKC on mGluR5b which cannot therefore be measured under our experimental conditions. The basal PLC activity of LLC-PKI cells expressing mGluR5a or b is higher than that measured in control cells. This is not due to residual Glu present in the buffer, since it has been Figure   11 . Effect of phenylglycine derivatives on mGluR5a and mGluRla.
'H-inositol-labeled LLC-PKl cells transiently expressing mGluR5a or mGluRla were preincubated for 10 min in Krebs medium containing 10 mM LiCl alone or in the presence of the indicated concentration (FM) of the phenylglycine derivatives. Cells were incubated for a further 30 min in the same medium (light bars) or after addition of 10X concentrated Glu solution (final concentration IO pM; durk bars). a, Statistically different from the control base; h, statistically different from the control Glu (t test, p < 0.01). Results are expressed as the ratio of 'H-IP produced over total radioactivity in the membranes, and are means i SEM of triplicate determinations from a typical experiment. This is, however, not the consequence of the coupling of this receptor to PLC since overexpression of other receptors that have even stronger PLC activity such as the PACAP or the VI vasopressin receptors does not increase basal PLC activity in these cells (Spengler et al., 1993) . This increase in PLC basal activity resulting from mGluR5 expression is also observed in HEK293 cells, indicating that this is not a particularity of LLC-PKI cells (unpublished results). It is therefore possible that mGluR5a and b have a high intrinsic activity in the absence of agonist. Recently, mutated receptors with high intrinsic activity have been described (for a review, see Coughlin, 1994) and more careful analysis revealed that many wild type receptors including &opioid receptors (Costa and Hertz, 1989 ) the (3~ 1 B, a2 and B2-adrenergic receptors (Kjelsberg et al., 1992; Chidiac et al., 1994; Samama et al., 1994; Tian et al., 1994) , the 5HT2c receptor (Barker et al., 1994) , and muscarinic receptors (Hilf and Jakobs, 1992) have intrinsic activity, even in their normal environment (Hilf and Jakobs, 1992) . It has been proposed that even in the absence of agonist, receptors exist in two conformational stages, an inactive stage R and an active stage R*. The action of the agonist may then be simply to change the equilibrium constant between these two stages. In LLC-PKl cells, both mGluR5a and mGluR5b stimulate CAMP formation. A similar effect was also observed with mGluR1 a but not with mGluRlb.
In CHO cells stably expressing mGluRs, stimulation of adenylyl cyclase was observed with mGluR 1 a (Aramori and Nakanishi, 1992) but not with mGluRSa (Abe et al., 1992) indicating that mGluR.5 under certain conditions can specifically activate PLC. It is possible that in LLCPKl cells the increased production of CAMP is a consequence of the activation of PLC. In agreement with this hypothesis is our observation that the IP and CAMP production stimulated by mGluR5a or b are equally sensitive to PdBu and staurosporine. However, activation of mGluR1 b, that also stimulates IP production in these cells, does not increase CAMP production. More work is therefore required to confirm a possible direct coupling of mGluR5 splice variants to adenylyl cyclase via activation of Gs proteins.
Taken together, these results indicate that the two mGluR5 variants possess all the functional characteristics of mGluRla ( Table 2 ) strongly suggesting that the long C-terminal domain of these 3 receptors, although having low homology, may have similar roles. It is actually possible that this long C-terminal domain allows the receptor to be expressed at a higher density at the cell surface, so that the high basal activity and the coupling to adenylyl cyclase can be detected. This possibility cannot actually be tested due to the absence of radioactive ligands with high enough affinity to do binding experiments on intact cells.
coupled mGluRs (Bashir et al., 1993) . Such an effect is however not observed by other authors (Chinestra et al., 1993 
